HDM201 and Midostaurin (HDMM) in Relapsed/Refractory AML With FLT3mut and TP53wt.

NCT04496999 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Insufficient recruitment

Conditions

AML, Adult

Interventions

DRUG: HDM201
DRUG: Midostaurin

Sponsor

Insel Gruppe AG, University Hospital Bern